MEDROL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Medrol, and what generic alternatives are available?
Medrol is a drug marketed by Pharmacia And Upjohn and Pfizer and is included in three NDAs.
The generic ingredient in MEDROL is methylprednisolone. There are two drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the methylprednisolone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Medrol
A generic version of MEDROL was approved as methylprednisolone by WATSON LABS on October 16th, 1997.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MEDROL?
- What are the global sales for MEDROL?
- What is Average Wholesale Price for MEDROL?
Summary for MEDROL
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 129 |
| Patent Applications: | 3,618 |
| Drug Prices: | Drug price information for MEDROL |
| What excipients (inactive ingredients) are in MEDROL? | MEDROL excipients list |
| DailyMed Link: | MEDROL at DailyMed |
Recent Clinical Trials for MEDROL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Vanderbilt University Medical Center | PHASE4 |
| St. Louis University | PHASE4 |
| Takeda | PHASE2 |
Pharmacology for MEDROL
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for MEDROL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacia And Upjohn | MEDROL | methylprednisolone acetate | ENEMA;RECTAL | 018102-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pfizer | MEDROL | methylprednisolone | TABLET;ORAL | 011153-006 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Pfizer | MEDROL | methylprednisolone | TABLET;ORAL | 011153-004 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
